| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.68B | +14.8% | +40.0% |
| R&D Expense | $922.0M | +23.9% | +70.7% |
| SG&A Expense | $1.83B | +7.8% | +41.0% |
| Operating Income | $747.0M | +58.9% | +167.4% |
| Pre-tax Income | $699.0M | +61.4% | +166.9% |
| Income Tax | $75.0M | +494.7% | +1400.0% |
| Net Income | $624.0M |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.29B | +9.3% | -54.6% |
| Accounts Receivable | $6.29B | +27.5% | +61.2% |
| Inventory | $9.03B | +30.7% | +11.6% |
| Current Assets | $29.36B | +16.5% | -7.0% |
| Total Assets | $79.51B | +4.9% | +17.2% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.59B | +119.7% | — |
| Investing Cash Flow | -$993.0M | -25.2% | — |
| Financing Cash Flow | -$2.09B | -54.7% | — |
| +38.1% |
| +159.4% |
| EPS (Basic) | $0.45 | +40.6% | +154.9% |
| EPS (Diluted) | $0.44 | +41.9% | +153.7% |
| $26.98B |
| +10.7% |
| +9.9% |
| Long-term Debt | $18.24B | +3.0% | +4.0% |
| Stockholders' Equity | $25.29B | +2.1% | +6.0% |